Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report) dropped 7.7% on Friday. The stock traded as low as $10.14 and last traded at $10.14. Approximately 1,300 shares were traded during trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.
Biotech Acquisition Stock Performance
The stock’s 50-day simple moving average is $10.14 and its 200 day simple moving average is $10.14.
About Biotech Acquisition
Biotech Acquisition Company is a special purpose acquisition company (SPAC) formed to identify and complete a business combination with a company in the biotechnology, biopharmaceutical, medical device or related life sciences industries.
Unlike an operating biotechnology company, Biotech Acquisition Company does not appear to develop or commercialize its own medicines, therapies or medical products. Its activities have centered on evaluating potential merger, acquisition or similar transactions that could provide a target company with access to public markets.
Publicly available information about the company’s operations, geographic reach, leadership and transaction history is limited.
Featured Stories
- Five stocks we like better than Biotech Acquisition
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
